| Bioactivity | EPYFGYSGAFK-13C9,15N3 (TFA) (EPYFGYSGAFK-13C9,15N3 (TFA)) is a 13C- and 15N-labeled compound. |
| Invitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 |
| Name | EPYFGYSGAFK-13C9,15N3 TFA |
| Formula | C5313C9H80N915N3O17.xC2HF3O2 |
| Molar Mass | 1277.30 (free base) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-279. |
EPYFGYSGAFK-13C9,15N3 TFA
CAS: F: C5313C9H80N915N3O17.xC2HF3O2 W: 1277.30 (free base)
EPYFGYSGAFK-13C9,15N3 (TFA) (EPYFGYSGAFK-13C9,15N3 (TFA)) is a 13C- and 15N-labeled compound.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.